These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

239 related items for PubMed ID: 10912093

  • 1. [How Germany manages it's diabetic patients].
    Einecke D.
    MMW Fortschr Med; 1999 Oct 21; 141(42):4-5. PubMed ID: 10912093
    [No Abstract] [Full Text] [Related]

  • 2. [It is worth concentrating on prevention of complications. An example from diabetic care].
    Tennvall GR, Rosenqvist U, Nilsson LG.
    Lakartidningen; 1997 Aug 20; 94(34):2817-21. PubMed ID: 9303991
    [No Abstract] [Full Text] [Related]

  • 3. Diabetes and rehab.
    Slovik DM.
    Rehab Manag; 1997 Aug 20; 10(2):46-8, 52-3, 116. PubMed ID: 10165951
    [No Abstract] [Full Text] [Related]

  • 4. [New medical care structures for patients with diabetes in Germany].
    Jecht M.
    MMW Fortschr Med; 2010 Nov 04; 152(44):96-8. PubMed ID: 21158186
    [No Abstract] [Full Text] [Related]

  • 5. [Patient classification and analysis of risk profiles for type 2 diabetics as the main focus point in practice. Results of the TEMPO study].
    Lippmann-Grob B, Bierwirth RA, Kron P, Leinhos B, Funke K, Huptas M, Grüneberg M, Weich KW, Münscher C, Potthoff F.
    Dtsch Med Wochenschr; 2004 Jan 16; 129(3):75-81. PubMed ID: 14724780
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Prevention and early therapy play too minor a role in our health care system].
    Rothe HJ.
    Med Klin (Munich); 2003 Oct 15; 98 Suppl 1():22-3. PubMed ID: 14694840
    [No Abstract] [Full Text] [Related]

  • 8. European comparison of costs and quality in the prevention of secondary complications in Type 2 diabetes mellitus (2000-2001).
    Gandjour A, Kleinschmit F, Lauterbach KW, INTERCARE International Investigators.
    Diabet Med; 2002 Jul 15; 19(7):594-601. PubMed ID: 12099964
    [Abstract] [Full Text] [Related]

  • 9. [Allocation of resources for the health care of diabetics. Panel of Experts, Ministry of Health and Consumption].
    Aten Primaria; 1996 Apr 30; 17(7):471-9. PubMed ID: 8679881
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. The cost-effectiveness of different management strategies for type I diabetes: a Swiss perspective.
    Palmer AJ, Weiss C, Sendi PP, Neeser K, Brandt A, Singh G, Wenzel H, Spinas GA.
    Diabetologia; 2000 Jan 30; 43(1):13-26. PubMed ID: 10672449
    [Abstract] [Full Text] [Related]

  • 12. [Comprehensive diabetes therapy despite budget controls. Challenges for the general practice team].
    Bucklitsch M, Lichte T.
    MMW Fortschr Med; 1999 Sep 09; 141(36):41. PubMed ID: 10904597
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Economics of type 2 diabetes prevention.
    Kissimova-Skarbek K.
    Przegl Lek; 2006 Sep 09; 63 Suppl 4():9-11. PubMed ID: 16967708
    [No Abstract] [Full Text] [Related]

  • 15. [Economic costs of diabetes mellitus: critical review and cost-benefit evaluation of proposed strategies for its reduction].
    Rubio JA, Alvarez J.
    Aten Primaria; 1998 Sep 15; 22(4):239-55. PubMed ID: 9803577
    [No Abstract] [Full Text] [Related]

  • 16. [Costs of long-term complications in type 2 diabetes patients in Germany. Results of the CODE-2 Study].
    Liebl A, Spannheimer A, Reitberger U, Görtz A.
    Med Klin (Munich); 2002 Dec 15; 97(12):713-9. PubMed ID: 12491064
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cross-sectional analysis of adult diabetes type 1 and type 2 patients with diabetic microvascular complications from a German retrospective observational study.
    Happich M, Breitscheidel L, Meisinger C, Ulbig M, Falkenstein P, Benter U, Watkins J.
    Curr Med Res Opin; 2007 Jun 15; 23(6):1367-74. PubMed ID: 17559744
    [Abstract] [Full Text] [Related]

  • 19. The economics of screening and treatment in type 2 diabetes mellitus.
    Raikou M, McGuire A.
    Pharmacoeconomics; 2003 Jun 15; 21(8):543-64. PubMed ID: 12751913
    [Abstract] [Full Text] [Related]

  • 20. [Insulin therapy in type 2 diabetes. Insured patients would be willing to pay for added benefits].
    MMW Fortschr Med; 2008 Dec 04; 150(49-50):56-7. PubMed ID: 19133372
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.